Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$410,000 |
 |
Gilead SciencesGILD |
-$1.21B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$98M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Norden Gregory | Aug 11, 2025 | Sell | 33,500 | $36.2313 | $1.2M |
| RIGGS RORY B | Jan 4, 2024 | Sell | 35,702 | $27.5476 | $980,000 |
| RIGGS RORY B | Jan 3, 2024 | Sell | 199,098 | $27.7867 | $5.5M |
| RIGGS RORY B | Jan 2, 2024 | Sell | 235,200 | $28.5165 | $6.7M |
| Giuliani Mario Germano | Dec 29, 2023 | Sell | 65,803 | $28.0444 | $1.8M |
| Giuliani Mario Germano | Dec 28, 2023 | Sell | 209,863 | $28.2038 | $5.9M |
| Giuliani Mario Germano | Dec 27, 2023 | Sell | 41,729 | $28.0082 | $1.2M |
| Giuliani Mario Germano | Dec 15, 2023 | Sell | 10,229 | $28.0085 | $290,000 |
| Giuliani Mario Germano | Dec 14, 2023 | Sell | 364,441 | $28.9053 | $11M |
| Giuliani Mario Germano | Dec 13, 2023 | Sell | 307,935 | $28.9542 | $8.9M |
What's the latest insider transaction for Royalty Pharma?
The most recent insider transaction for Royalty Pharma was conducted by Norden Gregory, who sold 33,500 shares on August 11, 2025 at a price of $36.23 per share.
Which insider has sold the most RPRX stock over the last two years?
Giuliani Mario Germano has sold the most RPRX stock in the last 2 years, with a total value of $29M.
What is the total value of insider transactions for Royalty Pharma (RPRX) in the last 2 years?
The total value of insider transactions for Royalty Pharma in the last 2 years is negative, amounting to -$43M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Royalty Pharma's market confidence?
Over the last 2 years, insider transactions for Royalty Pharma have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
